Effect of N-ras loss on MyoD transcriptional activity in Rb-deficient myoblasts. (A) MEFs of the indicated genotypes were transfected with an MCK promoter-reporter construct (MCK-luc; 0.25 μg), pCSA-MyoD (1.25 μg), and pCMV-β-gal (0.25 μg). Twenty-four hours later the cells were allowed to differentiate for 48 h. Luciferase and β-galactosidase were determined, and normalized fold activations were calculated relative to the corrected luciferase activity in the absence of MyoD. Results are the means ± standard errors for three independent experiments performed in triplicate. The numbers at the top are for the particular MEFs used. Groups 1 and 5; 2 and 6; and 3, 4, 7, and 8 are each derived from different litters. (B) MEFs (1, 4, 5, and 7; designations are as described for panel A) were transfected as described for panel A except that a MEF2-luc reporter was used. Fold activations were calculated relative to the corrected luciferase activity in the absence of MyoD. Results are the means ± standard errors for three independent experiments performed in triplicate. (C) MEFs (3 and 7; designations are as described for panel A) were transfected as described for panel A. As indicated, included in the transfections were plasmids encoding pRb (pBPJTR2-Rb; 0.25 μg), N-ras (pBabe-N-ras; 0.5 μg), or H-rasV12 (pCXN2-H-rasV12; 0.5 μg). Fold activations were calculated relative to the corrected luciferase activity in the absence of MyoD. Results are the means ± standard errors for three independent experiments performed in triplicate. (D) MEFs (3 and 7; designations are as described for panel A) were transfected as described for panel B. As indicated, included in the transfections were plasmids encoding N-ras (pBabe-N-ras; 0.5 μg) or H-rasV12 (pCXN2-H-rasV12; 0.5 μg). Fold activations were calculated relative to the corrected luciferase activity in the absence of MyoD. Results are the means ± standard errors for three independent experiments performed in triplicate. (E to J) MEFs (3, 5, and 7; designations are described for panel A) were infected with a MyoD-encoding retrovirus. The quantity of retrovirus-containing medium was adjusted such that approximately 1% of the cells formed myotubes in wild-type MEFs. Following differentiation, immunofluorescence was performed for MyoD (with fluorescein isothiocyanate) and MHC (with rhodamine). Nuclei were stained with DAPI. (K) Quantification of the results shown in panels E to G. The percentage of MyoD-positive cells that also showed strong staining for MHC was determined by analyzing equivalent numbers of total cells (∼1,000) for each genotype in 10 fields (magnification, ×10). The average percentage ± standard error is presented. All cells showing strong MHC staining were also MyoD positive.